Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan Dose Comparison in Multiple Myeloma Transplant
NCT00505895Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2002
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in multiple myeloma (MM), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2002; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00505895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505895.